Home Cart Sign in  
Chemical Structure| 2304621-31-4 Chemical Structure| 2304621-31-4

Structure of IMT1
CAS No.: 2304621-31-4

Chemical Structure| 2304621-31-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

IMT1 is a pioneering, specific, and non-competitive inhibitor of human mitochondrial RNA polymerase (POLRMT). IMT1 has potential applications in the research of mitochondrial transcription-related diseases.

Synonyms: LDC195943

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of IMT1

CAS No. :2304621-31-4
Formula : C21H21NO4
M.W : 351.40
SMILES Code : O=C1OC2=C(C(C3=C(C)C=CC=C3)=C1)C=CC(OC(C)C(N(C)C)=O)=C2
Synonyms :
LDC195943

Safety of IMT1

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of IMT1

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Immortalized MG63 cells 1 μM IMT1 significantly suppressed the viability of MG63 cells and induced cell death. PMC10791695
Immortalized HCT116 cells 1 μM IMT1 inhibited cell viability, induced cell death, and suppressed cell proliferation and migration. PMC11372113
Primary human colon cancer cells (pCan2 and pCan3) 1 μM IMT1 inhibited cell viability, induced cell death, and suppressed cell proliferation and migration. PMC11372113
Primary human colon cancer cells (pCan1) 0.1 μM to 5 μM 48 hours to 96 hours IMT1 significantly inhibited colony formation, cell viability, proliferation, cell cycle progression, and migration in pCan1 cells, and induced apoptosis and cell death. PMC11372113
Primary human osteoblasts (pOb) 1 μM IMT1 did not significantly reduce the viability of pOb cells or induce cell death. PMC10791695
HFOB1.19 osteoblastic cells 1 μM IMT1 did not significantly reduce the viability of hFOB1.19 cells or induce cell death. PMC10791695
Primary human osteosarcoma cells (pOS-2 and pOS-3) 1 μM IMT1 significantly suppressed the viability of pOS-2 and pOS-3 cells and induced cell death. PMC10791695
Primary human osteosarcoma cells (pOS-1) 0.04/0.2/1/5 μM 24-96 hours IMT1 dose-dependently suppressed the viability of pOS-1 cells. At 0.2-5 μM, the POLRMT inhibitor significantly decreased the CCK-8 viability of pOS-1 cells. PMC10791695
Primary human endometrial epithelial cells (phEE-1/phEE-2) 0.5 μM 48 hours IMT1 failed to significantly inhibit cell viability and proliferation. PMC9950144
Human umbilical vein endothelial cells (HUVECs) 0.5 µM 12 hours IMT1 inhibited HUVEC proliferation, migration, and capillary tube formation, causing mitochondrial depolarization, increased ROS, and decreased ATP. PMC11191269
Primary human endometrial carcinoma cells (phEC-2/phEC-3) 0.5 μM 48 hours IMT1 significantly inhibited cell viability and proliferation, and induced apoptosis. PMC9950144
Immortalized endometrial carcinoma cell lines (HEC-1/KLE) 0.5 μM 48 hours IMT1 significantly inhibited cell viability and proliferation, and induced apoptosis. PMC9950144
Primary human endometrial carcinoma cells (phEC-1) 0.02/0.1/0.5/2.5 μM 48 hours IMT1 efficiently decreased the viability of phEC-1 cells, significantly inhibited cell proliferation, migration, and induced apoptosis. PMC9950144
PCan1 cells 0.5 μM IMT1 inhibited POLRMT-dependent transcription, leading to mitochondrial depolarization, ROS production, and ATP reduction, inhibiting cell growth PMC10564732
MiaPaCa-2 cells 1 µM Evaluate the effect of IMT1 on cell viability, showing an IC50 value of 291.4 nM PMC8728608
HeLa cells 1 µM Assess the impact of IMT1 on mitochondrial transcript levels, showing a rapid decline PMC8728608
RKO cells 1 µM 96 hours Evaluate the effect of IMT1 on mitochondrial gene expression, showing a significant reduction in mitochondrial transcript levels PMC8728608
SD-1 cells 100-μm or 200-μm overnight culture Inhibition of mitochondrial transcription, reducing the release of mitochondrial dsRNA, thereby preventing the transition of MSCs to CAFs PMC11570786
Primary skin SCC cells (C1) 500 nM Inhibited proliferation and migration, induced mitochondrial depolarization and apoptosis PMC9349297

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice Primary colon cancer xenograft model Oral 50 mg/kg body weight Two cycles (on Day 0 and Day 3) Oral administration of IMT1 significantly inhibited the growth of primary colon cancer xenografts, suppressed POLRMT activity, disrupted mitochondrial function, hindered Akt-mTOR activation, and prompted apoptosis within the xenograft tissues. Additionally, IMT1 administration suppressed lung metastasis of primary colon cancer cells in nude mice. PMC11372113
Nude mice Osteosarcoma xenograft model Oral 50 mg/kg body weight Every 48 hours for a total of four rounds IMT1 significantly inhibited the growth of pOS-1 xenografts and induced apoptosis in tumor tissues. PMC10791695
C57BL/6 mice Diabetic retinopathy (DR) model Intravitreal injection 0.25 nM Single injection, examined after 48 hours IMT1 inhibited retinal angiogenesis, reducing vascular branches and branch points, and downregulated endothelial marker proteins. PMC11191269
Nude mice Endometrial carcinoma xenograft model Oral 50 mg/kg body weight Every 48 hours for five rounds IMT1 significantly inhibited the growth of endometrial carcinoma xenografts without apparent toxicity. PMC9950144
Nude mice Prostate cancer xenograft model Oral 50 mg/kg body weight Every 48 hours for five rounds IMT1 significantly inhibited the growth of prostate cancer xenografts PMC10564732

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.85mL

0.57mL

0.28mL

14.23mL

2.85mL

1.42mL

28.46mL

5.69mL

2.85mL

 

Historical Records

Categories